Bruker (BRKR) EBITDA Margin (2010 - 2026)
Bruker's (BRKR) quarterly EBITDA Margin came in at 7.79% in Q2 2026, down 928.0% on a YoY basis from 0.94% in Q2 2025, and down 728.67% quarter-over-quarter from 1.24% in Q1 2026.
Powered by 
Analysis
Bruker (BRKR) EBITDA Margin (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported EBITDA Margin for 17 consecutive years, with 7.79% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 928.0% year-over-year to 7.79%; the trailing twelve-month figure through Jun 2026 stood at 0.87% (down 622.0% YoY), and the FY2025 full-year result was 1.98%, down 553.0% from the prior year.
- EBITDA Margin fell to 7.79% in Q2 2026 per BRKR's latest filing, from 1.24% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.55% in Q3 2022 and bottomed at 7.79% in Q2 2026.
- Historically, EBITDA Margin has averaged 8.79% across 5 years, with a median of 8.43% in 2024.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin soared 196 bps in 2022, then plunged 1390 bps in 2025.
- Over 5 years, EBITDA Margin stood at 18.49% in 2022, then tumbled by 35 bps to 12.11% in 2023, then slumped by 39 bps to 7.36% in 2024, then climbed by 6 bps to 7.81% in 2025, then sank by 200 bps to 7.79% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 7.79%, 1.24%, and 7.81% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -12.95% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | -7.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.79% |
| Mar 31, 2026 | 1.24% |
| Dec 31, 2025 | 7.81% |
| Sep 30, 2025 | -6.02% |
| Jun 30, 2025 | 1.49% |
| Mar 31, 2025 | 3.97% |
| Dec 31, 2024 | 7.36% |
| Sep 30, 2024 | 7.88% |
| Jun 30, 2024 | 6.01% |
| Mar 31, 2024 | 8.98% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | 16.76% |
| Jun 30, 2023 | 12.64% |
| Mar 31, 2023 | 17.90% |
| Dec 31, 2022 | 18.49% |
| Sep 30, 2022 | 20.55% |
| Jun 30, 2022 | 12.56% |
| Mar 31, 2022 | 16.22% |
| Dec 31, 2021 | 18.35% |
| Sep 30, 2021 | 18.59% |